Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	23.87	27.27	28.02	31.81	49.33
Cash & Cash Equivalents	23.87	27.27	28.02	31.81	49.33
Cash Growth	-12.47%	-2.68%	-11.89%	-35.52%	-18.60%
Receivables	8.47	4.7	12.12	6.96	13.13
Inventory	6.77	5.78	4.04	2.46	2.86
Other Current Assets	1.85	2.13	3.08	3.4	3
Total Current Assets	40.97	39.89	47.26	44.63	68.31
Property, Plant & Equipment	9.74	9.3	7.78	10.32	9.73
Goodwill and Intangibles	1.28	1.44	0.05	0.1	0.15
Other Long-Term Assets	5.44	6.45	6.9	7.84	0.29
Total Long-Term Assets	16.45	17.18	14.73	18.26	10.17
Total Assets	57.42	57.07	61.99	62.88	78.48
Accounts Payable	8.93	9.95	8.31	7.09	12.27
Deferred Revenue	33.9	32.93	7.89	4.33	5.15
Current Debt	1.33	20.1	4.15	4.75	0
Other Current Liabilities	-25.85	-23.45	1.61	4.94	1.13
Total Current Liabilities	18.31	39.53	21.96	21.1	18.56
Long-Term Debt	111.24	102.65	112.56	84.7	60.34
Other Long-Term Liabilities	34.36	33.45	9.61	5.58	5.71
Total Long-Term Liabilities	145.6	136.1	122.16	90.28	66.05
Total Liabilities	163.91	175.62	144.13	111.38	84.6
Total Debt	112.57	122.75	116.71	89.45	60.34
Debt Growth	-8.29%	5.18%	30.47%	48.25%	27.83%
Retained Earnings	-319.08	-311.21	-256.8	-186.26	-130.47
Shareholders' Equity	-106.49	-118.55	-82.13	-48.5	-6.12
Net Cash / Debt	-88.7	-95.47	-88.68	-57.65	-11.01
Net Cash Per Share	-1.45	-1.96	-2.33	-1.71	-0.43
Working Capital	22.66	0.36	25.3	23.52	49.76
Book Value Per Share	-1.74	-2.43	-2.16	-1.44	-0.24

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).